本页面由Tiger Trade Technology Pte. Ltd.提供服务

MBX Biosciences

66.39
+0.06000.09%
盘后66.390.00000.00%19:30 EDT
成交量:53.11万
成交额:3,522.87万
市值:31.97亿
市盈率:-27.60
高:67.16
开:66.23
低:64.00
收:66.33
52周最高:72.64
52周最低:9.63
股本:4,816.01万
流通股本:2,762.99万
量比:1.07
换手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):-2.4052
每股收益(LYR):-2.3824
净资产收益率:-33.17%
总资产收益率:-22.08%
市净率:7.81
市盈率(LYR):-27.87

数据加载中...

2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities